Program Description
This SimulatEd™ program is an online, on-demand activity designed to enhance clinical reasoning for health care providers involved in the treatment of chronic lymphocytic leukemia (CLL). It consists of a simulated encounter with a patient who has progressed following front-line treatment. As the case evolves, learners will be prompted to make clinical decisions regarding optimal workup and management of CLL, as well as review key updates on emerging therapies. This activity aims to foster critical thinking and decision-making skills in a risk-free setting.
This program is provided by both Physicians’ Education Resource® and Pharmacy Times Continuing Education™.
Target audience: Oncology pharmacists
Release date: October 15, 2024
Expiration date: October 15, 2025
Educational Objectives
At the completion of this activity, participants will be able to:
- Apply relevant cytogenetic and molecular tests, including mutation testing, for patients with CLL/SLL
- Review ongoing and recent clinical trial data that evaluated subsequent therapeutic approaches for patients with CLL/SLL
- Demonstrate incorporation of evidence-based, patient-centered strategies in formulating treatment plans for patients with CLL/SLL
Catherine C. Coombs, MD
Associate Clinical Professor
Department of Medicine
Division of Hematology and Oncology
University of California, Irvine
Orange, CA
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.1 CEU) under the ACPE universal activity number 0290-9999-24-285-H01-P. The activity is available for CE credit through October 15, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Faculty, Staff, and Planners’ Disclosures
Catherine C. Coombs, MD has the following relevant financial relationship with a commercial interest to disclose:
Consultant: AbbVie, AstraZeneca, BeiGene, Genentech, Lilly, Octapharma.
Speaker’s Bureau: AbbVie, AstraZeneca, BeiGene, Genentech, Lilly.
Honoraria Recipient: AbbVie, Allogene, AstraZeneca, BeiGene, Genentech, Janssen, Lilly, MingSight.
Stockholder: bluebird bio, Geron, Pfizer.
The staff of Physicians’ Education Resource®, LLC, have no relevant financial relationships with ineligible companies.
PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
http://www.pharmacytimes.org/terms